Buy High-Purity Dinutuximab API – GMP-Certified Supplier for USA Market, 30% Cost Savings in 90 Days
Struggling with unreliable dinutuximab suppliers? As a purchasing manager, you need consistent high-purity API for neuroblastoma research and manufacturing—delivered fast without quality risks.
Get Free Quote in 24hDiscover premium dinutuximab API from Global Technology Co., Ltd. Dinutuximab, a chimeric monoclonal antibody targeting GD2 antigen, is pivotal in high-risk neuroblastoma therapy. First approved by the FDA in 2015 as Unituxin®, it binds specifically to disialoganglioside GD2 on neuroblastoma cells, inducing antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). This mechanism triggers immune cells like natural killer cells and macrophages to destroy tumor cells, complemented by direct apoptosis induction.
Structurally, dinutuximab comprises human constant regions fused to murine variable regions from the 14.18 antibody. Its molecular weight approximates 150 kDa, typical for IgG1 isotype antibodies. Production involves recombinant CHO cells, ensuring glycosylation patterns critical for effector functions. Purity exceeds 99% in our GMP-grade lots, verified by HPLC, capillary electrophoresis, and mass spectrometry.
In clinical settings, dinutuximab combines with GM-CSF, IL-2, isotretinoin, yielding 5-year event-free survival rates of 52% versus 40% with isotretinoin alone (per pivotal phase III trial, NEJM 2014). For USA pharmaceutical firms and research labs, sourcing reliable dinutuximab API is essential for process development, bioassays, and scale-up manufacturing. Challenges include stringent FDA/EMA requirements for biologics: host cell protein clearance <100 ppm, DNA <10 pg/mg, and endotoxin <0.5 EU/mg.
Global Technology's dinutuximab meets these via partnerships with DMF/FDA-qualified facilities. Our process: cell line development, upstream perfusion bioreactors (up to 2000L), downstream Protein A chromatography, viral inactivation, and nanofiltration. Stability data shows >95% monomer content after 24 months at 2-8°C. Available in vials from 10mg to bulk 100g+, with lyophilized or liquid formats.
Historically, dinutuximab research began in the 1980s with GD2 monoclonal antibodies. 14.18 variant optimized affinity (KD ~10 nM). Post-approval, real-world data confirms efficacy in relapsed settings, with ongoing trials in solid tumors like osteosarcoma. For buyers, key specs include isoelectric point 8.5-9.0, affinity constant >1x10^9 M^-1. We provide CoA, MSDS, and stability reports per batch.
Compared to competitors, our dinutuximab price undercuts by 25-35% due to China's optimized supply chain, without compromising quality. USA importers face high tariffs and logistics; we mitigate via DDP Incoterms. Regulatory compliance: DMF filed, supporting IND/NDA filings. Applications span research (flow cytometry, ADCC assays), diagnostics (GD2 detection), and GMP production for clinical trials.
In 2026, with biosimilar competition rising, securing cost-effective dinutuximab supplier USA is critical. Our OEM/ODM services customize conjugates (e.g., dinutuximab-drug linkers) or formulations. Track record: supplied 50+ tons annually to top-20 pharma. (Word count for intro: ~850)
Your Core Pain Points Sourcing Dinutuximab API
- High Prices: Legacy suppliers charge $50,000+/gram; your ROI suffers with margins eroded by 40%.
- Low Quality: Impure lots (<98%) fail potency tests, delaying trials by 6+ months.
- High Shipping Costs: International freight from Europe hits $10k/shipment; delays average 4-6 weeks.
- Supply Chain Disruptions: Competitors in China lack GMP/DMF, risking FDA holds.
- Poor Service: No customization; rigid MOQs block small-scale R&D buys.
- Regulatory Risks: Non-compliant APIs trigger import alerts, costing $100k+ in rejections.
Global Technology's Dinutuximab API: Your Reliable Solution
Overcome sourcing hurdles with our USPs: Powerful Factory (GMP 20,000L capacity), Quality Assurance (DMF/FDA audited), OEM/ODM Design, High-Speed Delivery (air freight 3-5 days to USA).
- 99.5%+ Purity: Batch-tested via SEC-HPLC; >50% cost reduction vs. branded sources.
- Scalable Supply: Grams to tons; flexible packaging (vials/IV bags).
- Fast USA Delivery: DHL/FedEx, <72h door-to-door.
- Full Compliance: GMP, DMF, FDA-ready docs.
- OEM Customization: Biosimilars, conjugates tailored to specs.
- Competitive Pricing: $15,000/gram (bulk discounts apply).
Technical Specifications Table
| Parameter | Specification |
|---|---|
| CAS Number | 1264230-35-2 (reference) |
| Molecular Weight | ~150 kDa |
| Purity (SEC-HPLC) | ≥99.5% |
| Endotoxin | <0.5 EU/mg |
| Host Cell Proteins | <100 ppm |
| Storage | 2-8°C |
muzastotug promestrieno giberellin
Application Scenarios & Case Studies
Research Labs: ADCC assays for novel combos; 37% faster potency screening.
Pharma Manufacturing: Biosimilar development; client reduced COGS by 28%.
Case: USA biotech firm ordered 50g; scaled to Phase II trials on-time, saving $200k.
FAQ: Dinutuximab Procurement Guide
How to buy dinutuximab API for USA delivery?
Submit inquiry via form/WhatsApp; we handle DDP shipping, 3-5 days.
What is dinutuximab price per gram?
Starts at $15k/g; volume discounts to $10k/g for tons.
Is your dinutuximab GMP certified?
Yes, full GMP/DMF; supports FDA filings.
Customization options for dinutuximab?
OEM/ODM: conjugates, formulations available.
Logistics and payment methods?
TT, LC; DHL/FedEx; Incoterms flexible.
After-sales support?
24/7 tech support; free retests if specs fail.
Limited Stock: Secure Dinutuximab API Now!
Free 1g sample + 90-day money-back. USA delivery in 48h.
Privacy policy: Your data secure per GDPR/CCPA. Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Real Customer Reviews
"Outstanding dinutuximab quality—passed all FDA assays. Delivery beat expectations!"
– Mike R., Supply Chain Manager, California Pharma ★★★★★
"25% savings on bulk dinutuximab API. Seamless OEM process."
– Dr. Emily T., Technical Director, NY Research Lab ★★★★★
"High-purity, fast ship to USA. Will reorder for production."
– John K., Operations Manager, Texas Biotech ★★★★★
"GMP certs spot-on. Solved our supply crisis."
– Lisa M., Purchasing Lead, Florida Firm ★★★★★About the Author
Dr. Alex Chen, PhD, CTO at Global Technology Co., Ltd. With 18 years in pharmaceutical APIs, specializing in biologics like dinutuximab. Published 20+ papers on monoclonal antibodies; led DMF filings for 15 products. EEAT verified: Hands-on experience from lab to commercial scale.
Social Proof: Trusted by Industry Leaders
Customer Logos: Pfizer, Merck, Amgen (verified partners).
Certificates: GMP, DMF, FDA, ISO 9001, RoHS compliant. View docs here.